{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T23:15:19Z","timestamp":1764890119075,"version":"3.46.0"},"reference-count":25,"publisher":"BMJ","issue":"10","license":[{"start":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:00:00Z","timestamp":1760918400000},"content-version":"unspecified","delay-in-days":19,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,9,26]]},"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The Omicron variant of SARS-CoV-2 has emerged as the predominant strain of COVID-19 since 2022. Its association with prior vaccines remained under investigation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Retrospective cohort study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Clinical data for patients, from 1 May 2022 to 31 January 2023, were extracted from the Chi-Mei Medical Center, Chiali electronic medical record databases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>Hospitalised COVID-19 patients in dedicated wards were enrolled in the study. Cases of COVID-19 reinfection and relapse were also included. Patients who did not have COVID-19, those with PCR repositivity, or those with incomplete laboratory data were excluded.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions<\/jats:title>\n                    <jats:p>Various doses of vaccines included primary series, additional dose and booster. The types of vaccines included ChAdOx1-S, mRNA-based vaccines and recombinant protein vaccine. The interval between the last vaccination date and the diagnosis date of COVID-19 was assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Primary and secondary outcome measure<\/jats:title>\n                    <jats:p>The primary outcome was all-cause mortality by day 30. The secondary outcomes were severe disease of COVID-19 and 90-day survival.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 469 cases, the adjusted HR for 30-day mortality in vaccinated compared with unvaccinated patients was 0.831 (95% CI 0.541 to 1.277; p=0.398), indicating no statistically significant association. Age, Charlson Comorbidity Index (CCI), quick Sequential Organ Failure Assessment score and administration of dexamethasone were recognised as powerful predictors for survival in multivariable analysis. In subgroup analysis, a statistically significant association with better 30-day survival was observed among patients aged &lt;75 years and those with CCI &lt;3.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Vaccination was associated with lower mortality in younger or low-CCI patients, but not in older or highly comorbid patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-094412","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T08:00:17Z","timestamp":1761033617000},"page":"e094412","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Association between COVID-19 vaccination status and mortality in hospitalised COVID-19 patients during the Omicron period: a retrospective cohort study in Taiwan"],"prefix":"10.1136","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-8319-3927","authenticated-orcid":false,"given":"Ming-Hung","family":"Chang","sequence":"first","affiliation":[{"name":"Chest Medicine, Internal Medicine, Chi Mei Medical Center Chiali Branch, Tainan, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4838-6921","authenticated-orcid":false,"given":"Shian-Chin","family":"Ko","sequence":"additional","affiliation":[{"name":"Chest Medicine, Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4364-8248","authenticated-orcid":false,"given":"Kuang-Ming","family":"Liao","sequence":"additional","affiliation":[{"name":"Chest Medicine, Internal Medicine, Chi Mei Medical Center Chiali Branch, Tainan, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5925-8477","authenticated-orcid":false,"given":"Chung-Han","family":"Ho","sequence":"additional","affiliation":[{"name":"Medical Research, Chi Mei Medical Center, Tainan, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,10,20]]},"reference":[{"key":"2025120415071526000_15.10.e094412.1","unstructured":"Centers for Disease Control and Prevention . Underlying conditions and the higher risk for severe covid-19. Available: https:\/\/www.cdc.gov\/covid\/hcp\/clinical-care\/underlying-conditions.html [Accessed 20 Aug 2024]."},{"key":"2025120415071526000_15.10.e094412.2","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2022.2027160","article-title":"The efficacy and effectiveness of the COVID-19 vaccines in reducing infection, severity, hospitalization, and mortality: a systematic review","volume":"18","author":"Mohammed","year":"2022","journal-title":"Hum Vaccin Immunother"},{"key":"2025120415071526000_15.10.e094412.3","doi-asserted-by":"publisher","DOI":"10.1001\/JAMA.2021.19499"},{"key":"2025120415071526000_15.10.e094412.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00677-2"},{"key":"2025120415071526000_15.10.e094412.5","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/S2213-2600(21)00380-5","article-title":"COVID-19 hospital admissions and deaths after BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2\u00b757 million people in Scotland (EAVE II): a prospective cohort study","volume":"9","author":"Agrawal","year":"2021","journal-title":"Lancet Respir Med"},{"key":"2025120415071526000_15.10.e094412.6","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-43357-7","article-title":"Epidemiology and analysis of SARS-CoV-2 Omicron subvariants BA.1 and 2 in Taiwan","volume":"13","author":"Liu","year":"2023","journal-title":"Sci Rep"},{"key":"2025120415071526000_15.10.e094412.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2020.11.028"},{"key":"2025120415071526000_15.10.e094412.8","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(87)90171-8"},{"key":"2025120415071526000_15.10.e094412.9","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.0287"},{"key":"2025120415071526000_15.10.e094412.10","unstructured":"World Health Organization . Therapeutics and covid-19: living guideline. 2023. Available: https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-therapeutics-2023.2 [Accessed 20 Aug 2024]."},{"key":"2025120415071526000_15.10.e094412.11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/22221751.2021.2017757","article-title":"The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron","volume":"11","author":"Zhang","year":"2022","journal-title":"Emerg Microbes Infect"},{"key":"2025120415071526000_15.10.e094412.12","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/s41564-022-01143-7","article-title":"SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway","volume":"7","author":"Willett","year":"2022","journal-title":"Nat Microbiol"},{"key":"2025120415071526000_15.10.e094412.13","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2119451"},{"key":"2025120415071526000_15.10.e094412.14","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1056\/NEJMoa2200797","article-title":"Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar","volume":"386","author":"Abu-Raddad","year":"2022","journal-title":"N Engl J Med"},{"key":"2025120415071526000_15.10.e094412.15","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-30895-3","article-title":"Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA.1 and BA.2 subvariants in Qatar","volume":"13","author":"Chemaitelly","year":"2022","journal-title":"Nat Commun"},{"key":"2025120415071526000_15.10.e094412.16","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)01656-7"},{"key":"2025120415071526000_15.10.e094412.17","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2023-012328","article-title":"Severity and outcomes of Omicron variant of SARS-CoV-2 compared to Delta variant and severity of Omicron sublineages: a systematic review and metanalysis","volume":"8","author":"Relan","year":"2023","journal-title":"BMJ Glob Health"},{"key":"2025120415071526000_15.10.e094412.18","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/j.dsx.2020.10.022","article-title":"Charlson comorbidity index and a composite of poor outcomes in COVID-19 patients: A systematic review and meta-analysis","volume":"14","author":"Tuty Kuswardhani","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"2025120415071526000_15.10.e094412.19","doi-asserted-by":"crossref","first-page":"182","DOI":"10.4103\/tcmj.tcmj_132_22","article-title":"Predictive performance of qSOFA in confirmed COVID-19 patients presenting to the emergency department","volume":"35","author":"Heydari","year":"2023","journal-title":"Tzu Chi Med J"},{"key":"2025120415071526000_15.10.e094412.20","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/ijlh.13288","article-title":"Absolute lymphocyte count is a prognostic marker in Covid-19: A retrospective cohort review","volume":"42","author":"Wagner","year":"2020","journal-title":"Int J Lab Hematol"},{"key":"2025120415071526000_15.10.e094412.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.04.086"},{"key":"2025120415071526000_15.10.e094412.22","doi-asserted-by":"publisher","DOI":"10.1016\/J.AJEM.2021.02.054"},{"key":"2025120415071526000_15.10.e094412.23","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s43587-022-00343-4","article-title":"Impaired CD4+ T cell response in older adults is associated with reduced immunogenicity and reactogenicity of mRNA COVID-19 vaccination","volume":"3","author":"Jo","year":"2023","journal-title":"Nat Aging"},{"key":"2025120415071526000_15.10.e094412.24","doi-asserted-by":"crossref","DOI":"10.1186\/s12985-023-02056-5","article-title":"Impact of comorbidities on the serological response to COVID-19 vaccination in a Taiwanese cohort","volume":"20","author":"Huang","year":"2023","journal-title":"Virol J"},{"key":"2025120415071526000_15.10.e094412.25","doi-asserted-by":"crossref","DOI":"10.1136\/bmjmed-2021-000104","article-title":"Effectiveness of BNT162b2, mRNA-1273, and ChAdOx1-S vaccines against severe covid-19 outcomes in a nationwide mass vaccination setting: cohort study","volume":"1","author":"Bouillon","year":"2022","journal-title":"Bmjmed"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-094412","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T23:11:46Z","timestamp":1764889906000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-094412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":25,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10,20]]},"published-print":{"date-parts":[[2025,10]]}},"alternative-id":["10.1136\/bmjopen-2024-094412"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-094412","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2025,10]]}}}